PR Newswire
Hoth Therapeutics Delivers 100% Clinical Response with ~50% Reduction in Disease Severity in Open-Label PK Cohort of EGFR-Treated Cancer Patients
📈
AI Sentiment
Highly Positive
9/10
Hoth Therapeutics Inc. News
Latest updates and market news for HOTH
1 news
Jan 22 - Jan 28, 2026
Page 1
Share this news page